Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,513 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Aprepitant inhibits cyclophosphamide bioactivation and thiotepa metabolism.
de Jonge ME, Huitema AD, Holtkamp MJ, van Dam SM, Beijnen JH, Rodenhuis S. de Jonge ME, et al. Among authors: beijnen jh. Cancer Chemother Pharmacol. 2005 Oct;56(4):370-8. doi: 10.1007/s00280-005-1005-4. Epub 2005 Apr 19. Cancer Chemother Pharmacol. 2005. PMID: 15838656 Clinical Trial.
Entrapment by Cremophor EL decreases the absorption of paclitaxel from the gut.
Bardelmeijer HA, Ouwehand M, Malingré MM, Schellens J, Beijnen JH, van Tellingen O. Bardelmeijer HA, et al. Among authors: beijnen jh. Cancer Chemother Pharmacol. 2002 Feb;49(2):119-25. doi: 10.1007/s00280-001-0394-2. Epub 2001 Nov 20. Cancer Chemother Pharmacol. 2002. PMID: 11862425
Population pharmacokinetics of the novel anticancer agent KRN7000.
Crul M, Mathôt RA, Giaccone G, Punt CA, Rosing H, Hillebrand MX, Ando Y, Nishi N, Tanaka H, Schellens JM, Beijnen JH. Crul M, et al. Among authors: beijnen jh. Cancer Chemother Pharmacol. 2002 Apr;49(4):287-93. doi: 10.1007/s00280-001-0413-3. Epub 2002 Jan 24. Cancer Chemother Pharmacol. 2002. PMID: 11914907 Clinical Trial.
Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.
Meerum Terwogt JM, Groenewegen G, Pluim D, Maliepaard M, Tibben MM, Huisman A, ten Bokkel Huinink WW, Schot M, Welbank H, Voest EE, Beijnen JH, Schellens JM. Meerum Terwogt JM, et al. Among authors: beijnen jh. Cancer Chemother Pharmacol. 2002 Mar;49(3):201-10. doi: 10.1007/s002800100371. Epub 2002 Jan 22. Cancer Chemother Pharmacol. 2002. PMID: 11935212 Clinical Trial.
Urinary and fecal excretion of topotecan in patients with malignant solid tumours.
Herben VM, Schoemaker nE, Rosing H, van Zomeren DM, ten Bokkel Huinink WW, Dubbelman R, Hearn S, Schellens JH, Beijnen JH. Herben VM, et al. Among authors: beijnen jh. Cancer Chemother Pharmacol. 2002 Jul;50(1):59-64. doi: 10.1007/s00280-002-0454-2. Epub 2002 Apr 5. Cancer Chemother Pharmacol. 2002. PMID: 12111113 Clinical Trial.
1,513 results